课题基金 / 基金详情

Studies in Bioorganic Chemistry and Chemical Biology - Investigating Fundamentals for Lead Applications

Studies in Bioorganic Chemistry and Chemical Biology - Investigating Fundamentals for Lead Applications
生物有机化学和化学生物学研究 - 研究先导应用的基础知识
批准号:
RGPIN-2015-06534
负责人:
Perrin, David
金额:
$6.48万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31

项目摘要

项目成果

Perrin, David的其他基金

相似基金

相关文献

中文摘要
翻译
我实验室的学员将化学反应的基本原理应用于生物分子,如肽、寡核苷酸、杂环、DNAzymes和硼酸盐,作为生物学中的探针和试剂。我们在化学和生物学的界面上,在这四个不同的领域发表了具有竞争力的文章。***我实验室的学员1)掌握杂原子功能化方面的先进合成方法,2)培养机械物理有机化学的关键能力,3)应用生物偶联、分子生物学和组合选择方面的技术。凭借这些独特的技能,学员在化学和生物学的界面上解决各种问题,在那里他们合成具有新颖和令人兴奋的特性的新化学实体,这些实体将创造新的知识,同时解决生物技术和医学中的衍生应用,测试与生物过程相关的机制假设。在过去的5年里,我们在高度重视的同行评审期刊上发表了研究成果:1)合成DNAzymes, 2)硼酸的物理有机研究,3)肽毒素的化学生物学,以及4)合成DNA启发的“Janus”杂环,用于序列特异性DNA识别。****在我的实验室中,我们正在研究的主要问题如下:*******1)合成配体对DNA的序列特异性识别是控制特定基因表达和研究细胞内DNA结构、功能和可及性的重要目标。新的杂环也被提出,以及正在进行的识别互补DNA碱基对的Janus-AT/GC核苷的研究。*******2)环肽的研究,其中二硫键被取代,以创造新的生物活性氧化还原惰性肽。拟议的工作在amanitin和phalloidin,持有线索的基本方面的蛋白质折叠识别的天然产物毒素。通过这些毒素的合成,我们已经确定了另外两种生物活性肽作为镇痛药和生长抑制剂的新的生物活性。***3)化学修饰的基于DNA的催化剂和适配体:核酸代表了一个令人兴奋的技术平台,用于选择能够进行医学和化学重要转化的催化剂和配体,特别是在含有蛋白质样功能的新型杂交DNA催化剂方面。这些催化剂对RNA裂解和传感是有用的。******4)生物学中的有机硼酸盐:我们已经进行了各种硼酸盐与亲电试剂和亲核试剂反应的基础研究,用于原始和氧化波化。这项工作的主要应用是18F-PET成像,它代表了临床前/临床成像的一种选择成像方式。我们对C-B和B-F键形成在新的生物探针和C-F键形成方法中的基本应用感兴趣。**
英文摘要
Trainees in my lab apply fundamental principles of chemical reactivity to biological molecules such as peptides, oligonucleotides, heterocycles, DNAzymes, and boronates as probes and reagents in biology. We have published competitively in these four disparate areas at the interface of chemistry and biology.***Trainees in my lab i) master aspects of advanced synthetic methods in heteroatom functionalization, ii) develop critical abilities in mechanistic physical organic chemistry, and iii) apply techniques in bioconjugation, molecular biology and combinatorial selection. With these unique skills, trainees attack diverse questions at the interface of chemistry and biology where they synthesize new chemical entities with novel and exciting properties that will create new knowledge while addressing spin-off applications in biotechnology and medicine that test mechanistic hypotheses related to biological processes. Over the past 5 years, we have published work in highly regarded, peer-reviewed journals on: 1) synthetic DNAzymes, 2) physical-organic studies of boronic acids 3) chemical biology of peptide toxins, and 4) synthesis of DNA-inspired "Janus"-heterocycles for the application of sequence-specific DNA recognition.****The major questions we are pursuing in my lab are the following:*******1) Sequence specific recognition of DNA by synthetic ligands represents an important goal for controlling specific gene expression and investigating DNA structure, function, and accessibility inside cells. New heterocycles are also proposed along with ongoing investigations of Janus-AT/GC nucleosides that recognize a complementary DNA base pair.*******2) Investigation of cyclic peptides where the disulfide bond is replaced to create new biologically active redox-inert peptides. Proposed work on amanitin and phalloidin, hold clues as to fundamental aspects of protein-fold recognition by natural product toxins. Through the synthesis of these toxins, we have identified new bioactivity in two other bioactive peptides as analgesics and growth suppressors.***3) Chemically Modified DNA-based catalysts and aptamers: Nucleic acids represent an exciting technological platform for selecting catalysts and ligands that are capable of medicinally and chemically important transformations, particularly in terms of novel hybrid DNA catalysts that contain protein-like functionalities. These catalysts are useful for RNA cleavage and for sensing. ******4) Organoboronates in biology: We have undertaken fundamental studies of various boronates for reaction with electrophiles and nucleophiles for proto and oxidative deboronation. A major application of this work is 18F-PET imaging which represents a choice imaging modality for preclinical/clinical imaging. We are interested in the fundamental applications of C-B and B-F bond formation for new bioprobes and methods for C-F bond formation. **
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Molecules, Methods, and Platforms at the Interface of Organic Chemistry and Chemical Biology
  • 批准号:
    RGPIN-2020-05461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $6.85万
  • 财政年份:
    2022
  • 负责人:
    Perrin, David
  • 依托单位:
An Open Access Liquid Chromatography Mass Spectrometer for Sample Characterization
  • 批准号:
    RTI-2022-00618
  • 项目类别:
    Research Tools and Instruments
  • 资助金额:
    $10.93万
  • 财政年份:
    2021
  • 负责人:
    Perrin, David
  • 依托单位:
New Molecules, Methods, and Platforms at the Interface of Organic Chemistry and Chemical Biology
  • 批准号:
    RGPIN-2020-05461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $6.85万
  • 财政年份:
    2021
  • 负责人:
    Perrin, David
  • 依托单位:
Antibody venom conjugates
  • 批准号:
    571337-2021
  • 项目类别:
    Alliance Grants
  • 资助金额:
    $2.15万
  • 财政年份:
    2021
  • 负责人:
    Perrin, David
  • 依托单位:
海外基金